These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 26459988)

  • 1. Induced pluripotent stem cells as a discovery tool for Alzheimer׳s disease.
    Sullivan SE; Young-Pearse TL
    Brain Res; 2017 Feb; 1656():98-106. PubMed ID: 26459988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induced pluripotent stem cell-derived neuronal cells from a sporadic Alzheimer's disease donor as a model for investigating AD-associated gene regulatory networks.
    Hossini AM; Megges M; Prigione A; Lichtner B; Toliat MR; Wruck W; Schröter F; Nuernberg P; Kroll H; Makrantonaki E; Zouboulis CC; Adjaye J
    BMC Genomics; 2015 Feb; 16(1):84. PubMed ID: 25765079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Pluripotent Stem Cells as In Vitro Models of Neurodegenerative Diseases.
    Machairaki V
    Adv Exp Med Biol; 2020; 1195():93-94. PubMed ID: 32468463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling ALS and FTD with iPSC-derived neurons.
    Lee S; Huang EJ
    Brain Res; 2017 Feb; 1656():88-97. PubMed ID: 26462653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer's disease.
    Marei HE; Khan MUA; Hasan A
    Cell Mol Biol Lett; 2023 Nov; 28(1):98. PubMed ID: 38031028
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Important advances in Alzheimer's disease from the use of induced pluripotent stem cells.
    Majolo F; Marinowic DR; Machado DC; Da Costa JC
    J Biomed Sci; 2019 Feb; 26(1):15. PubMed ID: 30728025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease-related amyloid-β induces synaptotoxicity in human iPS cell-derived neurons.
    Nieweg K; Andreyeva A; van Stegen B; Tanriöver G; Gottmann K
    Cell Death Dis; 2015 Apr; 6(4):e1709. PubMed ID: 25837485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induced pluripotent stem cells in Alzheimer's disease: applications for disease modeling and cell-replacement therapy.
    Yang J; Li S; He XB; Cheng C; Le W
    Mol Neurodegener; 2016 May; 11(1):39. PubMed ID: 27184028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling Cellular Crosstalk of Neuroinflammation Axis by Tri-cultures of iPSC-Derived Human Microglia, Astrocytes, and Neurons.
    Connolly K; Lehoux M; Assetta B; Huang YA
    Methods Mol Biol; 2023; 2683():79-87. PubMed ID: 37300768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling Huntington׳s disease with patient-derived neurons.
    Mattis VB; Svendsen CN
    Brain Res; 2017 Feb; 1656():76-87. PubMed ID: 26459990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling Alzheimer's disease with human induced pluripotent stem (iPS) cells.
    Mungenast AE; Siegert S; Tsai LH
    Mol Cell Neurosci; 2016 Jun; 73():13-31. PubMed ID: 26657644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. iPSC-derived cortical neurons to study sporadic Alzheimer disease: A transcriptome comparison with post-mortem brain samples.
    Verheijen MCT; Krauskopf J; Caiment F; Nazaruk M; Wen QF; van Herwijnen MHM; Hauser DA; Gajjar M; Verfaillie C; Vermeiren Y; De Deyn PP; Wittens MMJ; Sieben A; Engelborghs S; Dejonckheere W; Princen K; Griffioen G; Roggen EL; Briedé JJ
    Toxicol Lett; 2022 Mar; 356():89-99. PubMed ID: 34921933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling neurological diseases using iPSC-derived neural cells : iPSC modeling of neurological diseases.
    Li L; Chao J; Shi Y
    Cell Tissue Res; 2018 Jan; 371(1):143-151. PubMed ID: 29079884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced Pluripotent Stem Cell-Derived Astroglia: A New Tool for Research Towards the Treatment of Alzheimer's Disease.
    Atkinson-Dell R; Mohamet L
    Adv Exp Med Biol; 2019; 1175():383-405. PubMed ID: 31583596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human pluripotent stem cells as tools for neurodegenerative and neurodevelopmental disease modeling and drug discovery.
    Corti S; Faravelli I; Cardano M; Conti L
    Expert Opin Drug Discov; 2015 Jun; 10(6):615-29. PubMed ID: 25891144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Back and forth in time: Directing age in iPSC-derived lineages.
    Cornacchia D; Studer L
    Brain Res; 2017 Feb; 1656():14-26. PubMed ID: 26592774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modeling human neurological disorders with induced pluripotent stem cells.
    Imaizumi Y; Okano H
    J Neurochem; 2014 May; 129(3):388-99. PubMed ID: 24286589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-butylidenephthalide attenuates Alzheimer's disease-like cytopathy in Down syndrome induced pluripotent stem cell-derived neurons.
    Chang CY; Chen SM; Lu HE; Lai SM; Lai PS; Shen PW; Chen PY; Shen CI; Harn HJ; Lin SZ; Hwang SM; Su HL
    Sci Rep; 2015 Mar; 5():8744. PubMed ID: 25735452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modeling Alzheimer's disease with iPSC-derived brain cells.
    Penney J; Ralvenius WT; Tsai LH
    Mol Psychiatry; 2020 Jan; 25(1):148-167. PubMed ID: 31391546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential therapeutic applications of differentiated induced pluripotent stem cells (iPSCs) in the treatment of neurodegenerative diseases.
    Gao A; Peng Y; Deng Y; Qing H
    Neuroscience; 2013 Jan; 228():47-59. PubMed ID: 23069758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.